|
JP2004522411A
(ja)
|
2000-07-31 |
2004-07-29 |
ジーン ロジック インコーポレイテッド |
分子毒性学モデリング
|
|
AU2001286221B2
(en)
*
|
2000-09-13 |
2006-09-28 |
Chugai Seiyaku Kabushiki Kaisha |
Remedies for ischemic diseases
|
|
CZ20031569A3
(cs)
*
|
2000-12-07 |
2003-11-12 |
Gencell S. A. |
Polynukleotidy obsahující fragment sekvence v protisměru od genu CARP, vektory a expresní kazety, které je obsahují, a jejich použití
|
|
US20050124568A1
(en)
|
2001-05-18 |
2005-06-09 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of acetyl-CoA-carboxylase gene expression using short interfering nucleic acid (siNA)
|
|
US6964950B2
(en)
*
|
2001-07-25 |
2005-11-15 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of C-reactive protein expression
|
|
EP2428570B1
(en)
|
2001-09-28 |
2018-05-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microrna molecules
|
|
JP2006502693A
(ja)
|
2002-02-04 |
2006-01-26 |
ジーン ロジック インコーポレイテッド |
初代ラット肝細胞毒性モデリング
|
|
US20080214437A1
(en)
|
2002-09-06 |
2008-09-04 |
Mohapatra Shyam S |
Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
|
|
US7781415B2
(en)
|
2003-02-07 |
2010-08-24 |
Roche Madison Inc. |
Process for delivering sirna to cardiac muscle tissue
|
|
WO2005013901A2
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
WO2005017145A1
(ja)
|
2003-08-13 |
2005-02-24 |
Japan Biological Informatics Consortium |
機能性ｒｎａが制御する被制御遺伝子の同定・予測方法及びその利用方法
|
|
EP1713938A2
(en)
|
2004-02-09 |
2006-10-25 |
Thomas Jefferson University |
DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
|
|
WO2005078096A2
(en)
|
2004-02-09 |
2005-08-25 |
University Of Massachusetts |
Dual functional oligonucleotides for use in repressing mutant gene expression
|
|
CA2556435C
(en)
|
2004-02-13 |
2014-08-12 |
The Rockefeller University |
Anti-microrna oligonucleotide molecules
|
|
EP2471924A1
(en)
|
2004-05-28 |
2012-07-04 |
Asuragen, INC. |
Methods and compositions involving microRNA
|
|
US7635563B2
(en)
|
2004-06-30 |
2009-12-22 |
Massachusetts Institute Of Technology |
High throughput methods relating to microRNA expression analysis
|
|
WO2006013561A2
(en)
|
2004-08-02 |
2006-02-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions and methods for diagnosing and treating post traumatic stress disorder
|
|
JP2006101790A
(ja)
|
2004-10-06 |
2006-04-20 |
Japan Health Science Foundation |
高血圧症のリスクの評価方法
|
|
US20080269072A1
(en)
|
2004-10-21 |
2008-10-30 |
Hart Ronald P |
Rational Probe Optimization for Detection of MicroRNAs
|
|
ES2534300T3
(es)
|
2004-11-12 |
2015-04-21 |
Asuragen, Inc. |
Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
|
|
US9550990B2
(en)
|
2004-12-10 |
2017-01-24 |
Ionis Pharmaceuticals, Inc. |
Regulation of epigenetic control of gene expression
|
|
US20060185027A1
(en)
|
2004-12-23 |
2006-08-17 |
David Bartel |
Systems and methods for identifying miRNA targets and for altering miRNA and target expression
|
|
US20070099196A1
(en)
|
2004-12-29 |
2007-05-03 |
Sakari Kauppinen |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs
|
|
US8071306B2
(en)
|
2005-01-25 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Methods for quantitating small RNA molecules
|
|
EP1874936B1
(en)
|
2005-04-19 |
2013-10-30 |
BASF Plant Science GmbH |
Improved methods controlling gene expression
|
|
DK2002003T3
(en)
|
2005-05-27 |
2016-03-21 |
Ospedale San Raffaele Srl |
Gene vector comprising miRNA
|
|
WO2007035684A2
(en)
|
2005-09-16 |
2007-03-29 |
Primera Biosystems, Inc. |
Method for quantitative detection of short rna molecules
|
|
US20070092882A1
(en)
|
2005-10-21 |
2007-04-26 |
Hui Wang |
Analysis of microRNA
|
|
CA2634046A1
(en)
|
2005-12-12 |
2007-06-21 |
The University Of North Carolina At Chapel Hill |
Micrornas that regulate muscle cell proliferation and differentiation
|
|
US20100286044A1
(en)
|
2005-12-29 |
2010-11-11 |
Exiqon A/S |
Detection of tissue origin of cancer
|
|
EP2388328A1
(en)
|
2006-01-27 |
2011-11-23 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for the use in modulation of micrornas
|
|
CA3042781C
(en)
|
2006-04-03 |
2021-10-19 |
Roche Innovation Center Copenhagen A/S |
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
|
|
DK2056882T3
(da)
*
|
2006-08-01 |
2012-11-19 |
Univ Texas |
Identifikation af en mikro-rna, som aktiverer ekspression af en tung kæde med beta-myosin
|
|
US20090306181A1
(en)
|
2006-09-29 |
2009-12-10 |
Children's Medical Center Corporation |
Compositions and methods for evaluating and treating heart failure
|
|
JP2010505427A
(ja)
|
2006-10-09 |
2010-02-25 |
ジュリアス−マキシミリアンズ−ユニベルシタット ワーズブルグ |
心疾患の診断及び治療用マイクロＲＮＡ（ｍｉＲＮＡ）
|
|
AU2007323469B2
(en)
|
2006-11-23 |
2014-07-24 |
Guangdong Maijinjia Biotechnology Co., Ltd |
Oligonucleotides for modulating target RNA activity
|
|
BRPI0719995A2
(pt)
|
2006-12-14 |
2014-03-18 |
Novartis Ag |
Composições e métodos para tratar distúrbios musculares & cardiovasculares
|
|
EP3536788A1
(en)
|
2006-12-21 |
2019-09-11 |
QIAGEN GmbH |
Microrna target site blocking oligos and uses thereof
|
|
US20090137504A1
(en)
|
2006-12-21 |
2009-05-28 |
Soren Morgenthaler Echwald |
Microrna target site blocking oligos and uses thereof
|
|
WO2008147839A1
(en)
|
2007-05-23 |
2008-12-04 |
Dharmacon, Inc. |
Micro-rna scaffolds and non-naturally occurring micro-rnas
|
|
CA2694928A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Board Of Regents, The University Of Texas System |
Micro-rnas that control myosin expression and myofiber identity
|
|
WO2009026574A2
(en)
|
2007-08-23 |
2009-02-26 |
Keren Pharmaceutical, Inc. |
Immunogenic compositions and uses thereof
|
|
DK2205737T3
(da)
|
2007-10-04 |
2013-05-21 |
Santaris Pharma As |
Mikromirer
|
|
WO2009058818A2
(en)
|
2007-10-29 |
2009-05-07 |
The Board Of Regents Of The University Of Texas System |
Compositions comprising a micro-rna and methods of their use in regulating cardiac remodeling
|
|
WO2009062169A2
(en)
|
2007-11-09 |
2009-05-14 |
The Board Of Regents Of The University Of Texas System |
Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair
|
|
US20110160285A1
(en)
|
2008-03-13 |
2011-06-30 |
The Regents Of The University Of Colorado |
Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy
|
|
US20090326049A1
(en)
|
2008-04-04 |
2009-12-31 |
Alexander Aristarkhov |
Blocking oligos for inhibition of microrna and sirna activity and uses thereof
|
|
CA2726052A1
(en)
|
2008-06-04 |
2009-12-10 |
The Board Of Regents Of The University Of Texas System |
Modulation of gene expression through endogenous small rna targeting of gene promoters
|
|
US8193161B2
(en)
|
2008-06-09 |
2012-06-05 |
New York Medical College |
Compositions comprising cardiac stem cells overexpressing specific micrornas and methods of their use in repairing damaged myocardium
|
|
EP2447274B1
(en)
|
2008-10-24 |
2017-10-04 |
Ionis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|